Revelation Biosciences, Inc. (REVB) Stock Forecast & Price Target
Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 13, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)
Revenue and earnings estimates published by analysts covering Revelation Biosciences, Inc. (REVB), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.
For Revelation Biosciences, Inc., the average estimate for 2030 earnings per share is $14.46; 2 analysts contribute to these figures. These are forecasts published by analysts, not results.
Revenue forecast (USD)
The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.
Earnings per share forecast
Revelation Biosciences, Inc. (REVB) forecast — frequently asked questions
What are analysts forecasting for Revelation Biosciences, Inc.'s earnings?
The average analyst estimate for Revelation Biosciences, Inc. (REVB) earnings per share in 2030 is 14.46, with individual estimates between 14.46 and 14.46.
How much revenue is Revelation Biosciences, Inc. expected to make?
Analysts forecast Revelation Biosciences, Inc. (REVB) revenue of $101.38M in 2030, based on 1 published estimates.
How many analysts cover REVB?
2 analysts contribute estimates for Revelation Biosciences, Inc. (REVB). Thin coverage makes an average less reliable.
Analyst forecasts for other Biotechnology stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.